captopril has been researched along with nitrocefin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brem, J; Cain, R; Fishwick, CW; Owens, RJ; Rydzik, AM; Salimraj, R; Schofield, CJ; Spencer, J; van Berkel, SS; Verma, A | 1 |
| Dideberg, O; Garau, G; Hernandez, JF; Kahn, R; Nauton, L | 1 |
2 other study(ies) available for captopril and nitrocefin
| Article | Year |
|---|---|
Assay platform for clinically relevant metallo-β-lactamases.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Enzyme Inhibitors; Magnetic Resonance Spectroscopy; Mass Spectrometry; Metals | 2013 |
Structural insights into the design of inhibitors for the L1 metallo-beta-lactamase from Stenotrophomonas maltophilia.
Topics: Anti-Bacterial Agents; Apoenzymes; beta-Lactamase Inhibitors; beta-Lactamases; Binding Sites; Captopril; Cephalosporins; Enzyme Inhibitors; Escherichia coli; Hydrogen Bonding; Hydrogen-Ion Concentration; Indicators and Reagents; Inhibitory Concentration 50; Ligands; Models, Molecular; Molecular Structure; Moxalactam; Protein Binding; Protein Structure, Secondary; Stenotrophomonas maltophilia; Stereoisomerism; Substrate Specificity; Sulfates; Water; X-Ray Diffraction; Zinc | 2008 |